CD40 and focal segmental glomerulosclerosis: Further studies are needed in order to elucidate the mechanisms of CD40 activation in spontaneous human glomerular pathology, and to develop possible new therapeutic approaches to block the CD40-CD40L axis with the aim to inhibit progression and/or recurrence of FSGS.